Professor Hansford is a mid-career clinician specializing in the treatment of paediatric brain tumours. He has a long-standing interest in cancer genetics post the completion of his Master’s of Science (Pathology – Cancer Genetics, Queen’s University, Canada). Upon the completion of his clinical training and admission to fellowship (FRACP), he relocated to Melbourne to re-invigorate the largest paediatric neuro-oncology practice in the country. While in Melbourne they increased their pre-clinical and clinical collaborations with groups both nationally and internationally, resulting in a marked increase in their research output with over 60 papers already accepted and many manuscripts and abstracts in preparation. In late 2016 he was appointed the lead of the Neuro-Oncology group and remained in that role until taking his current role in South Australia. He is a PI or co-PI on several national and international brain tumour studies including early phase studies. In 2018, he was named as the site Principal Investigator for the Children’s Oncology Group and lead of clinical research. In 2019, he was named Associate Professor of Paediatrics at the University of Melbourne. In 2022 he was named Professor at University of Adelaide through the affiliate South Australian Immuno-genomics Cancer Institute and Team Leader, Program Leader – Paediatric Neuro-Oncology at South Australian Health and Medical Research Institute and clinical lead in Neuro-Oncology at the Women’s and Children’s Hospital in Adelaide. His main focus will include leading the Proton Radiotherapy integration team.